Jeffrey Del - Aug 9, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role: Chief Commercial Officer
Signature: /s/ Jeffrey Del Carmen
Stock symbol: CPRX
Transactions as of: Aug 9, 2024
Transactions value $: -$578,510
Form type: 4
Date filed: 8/13/2024, 05:01 PM
Previous filing: Jun 11, 2024
Next filing: Nov 25, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CPRX	Common stock, par value $0.001 per share	Sale	-$112K	-6.06K	-32.88%	$18.44	12.4K	Aug 9, 2024	Direct	F1
transaction	CPRX	Common stock, par value $0.001 per share	Options Exercise	$85.8K	+30K	+242.54%	$2.86	42.4K	Aug 9, 2024	Direct
transaction	CPRX	Common stock, par value $0.001 per share	Sale	-$553K	-30K	-70.81%	$18.42	12.4K	Aug 9, 2024	Direct	F1, F2

Showing 1 to 3 of 3 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CPRX	Options to purchase common stock	Options Exercise	$0	-30K	-3.6%	$0.00	804K	Aug 9, 2024	Common Stock	30K	$2.86	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2	Shares were sold in various lots from $18.33 to $18.48 per share. The price listed represents a weighted average price for the shares sold.
F3	Shares vested in five annual tranches beginning on August 6, 2019.